This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!
Genomic Health Inc
GHDX : NASDAQ : Health Care
$32.69 0.25 | 0.77%
Today's Range: 32.16 - 33.43
Avg. Daily Volume: 153,400
12/26/14 - 1:00 PM ET

PEER GROUP: Biotechnology



Ticker Company Name Recent
Price($)
Market
Cap($M)
Price/
Earnings
Net Sales
TTM($M)
Net Income
TTM($M)
GHDX GENOMIC HEALTH INC 31.44 997.34 n/m 275.40 8.76
MGNX MACROGENICS INC 33.83 940.30 n/m 57.23 182.85
IMGN IMMUNOGEN INC 10.85 932.41 n/m 55.88 14.83
ARNA ARENA PHARMACEUTICALS INC 4.04 889.26 n/m 34.30 -55.36
INFI INFINITY PHARMACEUTICALS INC 17.19 838.30 n/m 160.64 n/a
ENTA ENANTA PHARMACEUTICALS INC 44.88 834.95 25.50 47.74 1038.31
AMAG AMAG PHARMACEUTICALS INC 43.30 1095.71 n/m 92.84 15.63
SGMO SANGAMO BIOSCIENCES INC 15.72 1075.31 n/m 37.79 44.24
NLNK NEWLINK GENETICS CORP 37.21 1040.39 n/m 3.64 231.60
LGND LIGAND PHARMACEUTICAL INC 52.13 1024.15 162.91 56.28 17.55
EBS EMERGENT BIOSOLUTIONS INC 26.98 1013.15 56.21 400.27 29.43
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

GHDX Ind Avg S&P 500
n/m 71.67 19.99
 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades


Top Rated Stocks Top Rated Funds Top Rated ETFs